Century Therapeutics CEO Pfeiffenberger sells 32,456 shares at $0.45 on Nov 17.

miércoles, 19 de noviembre de 2025, 4:30 pm ET1 min de lectura
IPSC--

Century Therapeutics, Inc., a biotechnology company specializing in induced pluripotent stem cell (IPSC) technology, has announced that its Director, President, and Chief Executive Officer, Brent Pfeiffenberger, has recently sold 32,456 shares of the company's stock at a price of $0.45 per share on November 17, 2025.

Century Therapeutics CEO Pfeiffenberger sells 32,456 shares at $0.45 on Nov 17.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios